nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.123	0.351	CbGbCtD
Tramadol—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0528	0.15	CbGbCtD
Tramadol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0408	0.116	CbGbCtD
Tramadol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0379	0.108	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0354	0.101	CbGbCtD
Tramadol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0174	0.0495	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0171	0.0486	CbGbCtD
Tramadol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0159	0.0453	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0109	0.0309	CbGbCtD
Tramadol—Venlafaxine—ABCB1—peripheral nervous system neoplasm	0.00235	0.695	CrCbGaD
Tramadol—Dextromethorphan—ABCB1—peripheral nervous system neoplasm	0.00103	0.304	CrCbGaD
Tramadol—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000211	CcSEcCtD
Tramadol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000135	0.00021	CcSEcCtD
Tramadol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00021	CcSEcCtD
Tramadol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.00021	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000209	CcSEcCtD
Tramadol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000134	0.000209	CcSEcCtD
Tramadol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000133	0.000208	CcSEcCtD
Tramadol—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000207	CcSEcCtD
Tramadol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000133	0.000207	CcSEcCtD
Tramadol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000207	CcSEcCtD
Tramadol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000132	0.000207	CcSEcCtD
Tramadol—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000205	CcSEcCtD
Tramadol—Pain—Etoposide—peripheral nervous system neoplasm	0.000131	0.000205	CcSEcCtD
Tramadol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000131	0.000205	CcSEcCtD
Tramadol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000205	CcSEcCtD
Tramadol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000205	CcSEcCtD
Tramadol—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000204	CcSEcCtD
Tramadol—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000203	CcSEcCtD
Tramadol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000203	CcSEcCtD
Tramadol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00013	0.000202	CcSEcCtD
Tramadol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000202	CcSEcCtD
Tramadol—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000202	CcSEcCtD
Tramadol—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000201	CcSEcCtD
Tramadol—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000199	CcSEcCtD
Tramadol—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000199	CcSEcCtD
Tramadol—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000199	CcSEcCtD
Tramadol—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000198	CcSEcCtD
Tramadol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000198	CcSEcCtD
Tramadol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000126	0.000197	CcSEcCtD
Tramadol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000197	CcSEcCtD
Tramadol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.000197	CcSEcCtD
Tramadol—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000196	CcSEcCtD
Tramadol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000126	0.000196	CcSEcCtD
Tramadol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000125	0.000196	CcSEcCtD
Tramadol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.000195	CcSEcCtD
Tramadol—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000195	CcSEcCtD
Tramadol—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000195	CcSEcCtD
Tramadol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000194	CcSEcCtD
Tramadol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000193	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000193	CcSEcCtD
Tramadol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000193	CcSEcCtD
Tramadol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000192	CcSEcCtD
Tramadol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000123	0.000192	CcSEcCtD
Tramadol—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000192	CcSEcCtD
Tramadol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000122	0.00019	CcSEcCtD
Tramadol—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00019	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00019	CcSEcCtD
Tramadol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00019	CcSEcCtD
Tramadol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000121	0.000189	CcSEcCtD
Tramadol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000121	0.000189	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000189	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000189	CcSEcCtD
Tramadol—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000189	CcSEcCtD
Tramadol—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000189	CcSEcCtD
Tramadol—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000188	CcSEcCtD
Tramadol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00012	0.000188	CcSEcCtD
Tramadol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000188	CcSEcCtD
Tramadol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000188	CcSEcCtD
Tramadol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000187	CcSEcCtD
Tramadol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000187	CcSEcCtD
Tramadol—Rash—Vincristine—peripheral nervous system neoplasm	0.000119	0.000186	CcSEcCtD
Tramadol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000119	0.000186	CcSEcCtD
Tramadol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000186	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000186	CcSEcCtD
Tramadol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000186	CcSEcCtD
Tramadol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000185	CcSEcCtD
Tramadol—Headache—Vincristine—peripheral nervous system neoplasm	0.000119	0.000185	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000184	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000184	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000183	CcSEcCtD
Tramadol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000182	CcSEcCtD
Tramadol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000182	CcSEcCtD
Tramadol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000179	CcSEcCtD
Tramadol—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000179	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000178	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000177	CcSEcCtD
Tramadol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000113	0.000177	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000176	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000176	CcSEcCtD
Tramadol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000113	0.000176	CcSEcCtD
Tramadol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000175	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000175	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000175	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000175	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000175	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000174	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000174	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000173	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000172	CcSEcCtD
Tramadol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00011	0.000172	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000172	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000172	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000171	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000171	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00017	CcSEcCtD
Tramadol—Chills—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00017	CcSEcCtD
Tramadol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000109	0.00017	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000169	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000169	CcSEcCtD
Tramadol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000166	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000166	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000165	CcSEcCtD
Tramadol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000165	CcSEcCtD
Tramadol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000165	CcSEcCtD
Tramadol—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000165	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000165	CcSEcCtD
Tramadol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000105	0.000164	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000163	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000163	CcSEcCtD
Tramadol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000162	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000162	CcSEcCtD
Tramadol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000162	CcSEcCtD
Tramadol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000161	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000161	CcSEcCtD
Tramadol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00016	CcSEcCtD
Tramadol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000159	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000159	CcSEcCtD
Tramadol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000102	0.000158	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000158	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000158	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000158	CcSEcCtD
Tramadol—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000157	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000156	CcSEcCtD
Tramadol—Nausea—Cisplatin—peripheral nervous system neoplasm	9.95e-05	0.000155	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000155	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	9.82e-05	0.000153	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	9.78e-05	0.000153	CcSEcCtD
Tramadol—Vomiting—Etoposide—peripheral nervous system neoplasm	9.76e-05	0.000152	CcSEcCtD
Tramadol—Erythema—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.000152	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.000152	CcSEcCtD
Tramadol—Anaemia—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000152	CcSEcCtD
Tramadol—Agitation—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000151	CcSEcCtD
Tramadol—Rash—Etoposide—peripheral nervous system neoplasm	9.68e-05	0.000151	CcSEcCtD
Tramadol—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.67e-05	0.000151	CcSEcCtD
Tramadol—Headache—Etoposide—peripheral nervous system neoplasm	9.62e-05	0.00015	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.00015	CcSEcCtD
Tramadol—Tension—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000149	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.000149	CcSEcCtD
Tramadol—Malaise—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000148	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.000148	CcSEcCtD
Tramadol—Vertigo—Epirubicin—peripheral nervous system neoplasm	9.47e-05	0.000148	CcSEcCtD
Tramadol—Syncope—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000148	CcSEcCtD
Tramadol—Back pain—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.000147	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000146	CcSEcCtD
Tramadol—Palpitations—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000145	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000145	CcSEcCtD
Tramadol—Cough—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000144	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	9.19e-05	0.000144	CcSEcCtD
Tramadol—Convulsion—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000143	CcSEcCtD
Tramadol—Nausea—Etoposide—peripheral nervous system neoplasm	9.12e-05	0.000142	CcSEcCtD
Tramadol—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000142	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.05e-05	0.000141	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.02e-05	0.000141	CcSEcCtD
Tramadol—Myalgia—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.00014	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.00014	CcSEcCtD
Tramadol—Chest pain—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.00014	CcSEcCtD
Tramadol—Agitation—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.00014	CcSEcCtD
Tramadol—Anxiety—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.00014	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000139	CcSEcCtD
Tramadol—Discomfort—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000138	CcSEcCtD
Tramadol—Malaise—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000137	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	8.78e-05	0.000137	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000137	CcSEcCtD
Tramadol—Syncope—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.000137	CcSEcCtD
Tramadol—Confusional state—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000135	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000135	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	8.6e-05	0.000134	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000134	CcSEcCtD
Tramadol—Infection—Epirubicin—peripheral nervous system neoplasm	8.55e-05	0.000133	CcSEcCtD
Tramadol—Cough—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000133	CcSEcCtD
Tramadol—Shock—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000132	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000132	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000132	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.42e-05	0.000132	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000131	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.4e-05	0.000131	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.00013	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.00013	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.00013	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.00013	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.00013	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000129	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000129	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000128	CcSEcCtD
Tramadol—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000128	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.000127	CcSEcCtD
Tramadol—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000126	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000125	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	7.96e-05	0.000124	CcSEcCtD
Tramadol—Infection—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000123	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000122	CcSEcCtD
Tramadol—Shock—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000122	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000122	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	7.79e-05	0.000122	CcSEcCtD
Tramadol—Insomnia—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000121	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000121	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000121	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000121	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.00012	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.00012	CcSEcCtD
Tramadol—Somnolence—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000119	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000118	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000118	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000117	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000116	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000116	CcSEcCtD
Tramadol—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000116	CcSEcCtD
Tramadol—Constipation—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000115	CcSEcCtD
Tramadol—Pain—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000115	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.000113	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000112	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000112	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000111	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000111	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.00011	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.00011	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000109	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000108	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000107	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000107	CcSEcCtD
Tramadol—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000107	CcSEcCtD
Tramadol—Pain—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000106	CcSEcCtD
Tramadol—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000106	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000106	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000106	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000102	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000102	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.34e-05	9.9e-05	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	9.87e-05	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	9.82e-05	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	9.82e-05	CcSEcCtD
Tramadol—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.17e-05	9.64e-05	CcSEcCtD
Tramadol—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.09e-05	9.5e-05	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.89e-05	9.19e-05	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	9.16e-05	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	8.92e-05	CcSEcCtD
Tramadol—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.69e-05	8.88e-05	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	8.79e-05	CcSEcCtD
Tramadol—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.47e-05	8.54e-05	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.45e-05	8.5e-05	CcSEcCtD
Tramadol—Rash—Epirubicin—peripheral nervous system neoplasm	5.42e-05	8.47e-05	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.42e-05	8.46e-05	CcSEcCtD
Tramadol—Headache—Epirubicin—peripheral nervous system neoplasm	5.39e-05	8.41e-05	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	8.22e-05	CcSEcCtD
Tramadol—Nausea—Epirubicin—peripheral nervous system neoplasm	5.11e-05	7.98e-05	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	7.9e-05	CcSEcCtD
Tramadol—Rash—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	7.84e-05	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	7.83e-05	CcSEcCtD
Tramadol—Headache—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	7.79e-05	CcSEcCtD
Tramadol—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	7.38e-05	CcSEcCtD
Tramadol—OPRK1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	2.23e-05	0.00508	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	2.23e-05	0.00506	CbGpPWpGaD
Tramadol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.2e-05	0.005	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.18e-05	0.00497	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.09e-05	0.00476	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	2.02e-05	0.0046	CbGpPWpGaD
Tramadol—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.01e-05	0.00458	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	1.95e-05	0.00444	CbGpPWpGaD
Tramadol—HTR2C—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	1.94e-05	0.00442	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.94e-05	0.00441	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.93e-05	0.0044	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	1.89e-05	0.00429	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	1.88e-05	0.00428	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	1.8e-05	0.0041	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.77e-05	0.00404	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.76e-05	0.004	CbGpPWpGaD
Tramadol—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	1.76e-05	0.004	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	1.74e-05	0.00396	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.7e-05	0.00387	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.69e-05	0.00384	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	1.67e-05	0.00381	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	1.65e-05	0.00375	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.54e-05	0.00351	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.54e-05	0.00351	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.5e-05	0.00341	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	1.5e-05	0.00341	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.48e-05	0.00337	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.47e-05	0.00334	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.44e-05	0.00327	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.41e-05	0.00322	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.4e-05	0.00317	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.35e-05	0.00307	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.35e-05	0.00307	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.33e-05	0.00304	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.3e-05	0.00297	CbGpPWpGaD
Tramadol—OPRM1—IL4-mediated signaling events—AKT1—peripheral nervous system neoplasm	1.29e-05	0.00294	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.29e-05	0.00293	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.29e-05	0.00293	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.25e-05	0.00285	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.23e-05	0.00281	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.23e-05	0.0028	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.2e-05	0.00273	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.18e-05	0.00269	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.17e-05	0.00266	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.14e-05	0.0026	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.12e-05	0.00255	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.11e-05	0.00252	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.09e-05	0.00248	CbGpPWpGaD
Tramadol—OPRM1—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	1.09e-05	0.00247	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.08e-05	0.00246	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.07e-05	0.00244	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.06e-05	0.00242	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.0024	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.04e-05	0.00237	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.02e-05	0.00233	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.99e-06	0.00227	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.97e-06	0.00227	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.88e-06	0.00225	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.81e-06	0.00223	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	9.64e-06	0.00219	CbGpPWpGaD
Tramadol—OPRM1—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	9.59e-06	0.00218	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.42e-06	0.00214	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.35e-06	0.00213	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.25e-06	0.0021	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.12e-06	0.00208	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NTS—peripheral nervous system neoplasm	9.12e-06	0.00207	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	9.1e-06	0.00207	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.74e-06	0.00199	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.71e-06	0.00198	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.58e-06	0.00195	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.49e-06	0.00193	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.44e-06	0.00192	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.34e-06	0.0019	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.24e-06	0.00187	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.11e-06	0.00184	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.08e-06	0.00184	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.05e-06	0.00183	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.91e-06	0.0018	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.88e-06	0.00179	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.83e-06	0.00178	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.71e-06	0.00175	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.64e-06	0.00174	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.62e-06	0.00173	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.4e-06	0.00168	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.39e-06	0.00168	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.38e-06	0.00168	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	7.34e-06	0.00167	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.31e-06	0.00166	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.27e-06	0.00165	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.93e-06	0.00158	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.92e-06	0.00157	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.91e-06	0.00157	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GNS—peripheral nervous system neoplasm	6.81e-06	0.00155	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.74e-06	0.00153	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.68e-06	0.00152	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.62e-06	0.00151	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NME1—peripheral nervous system neoplasm	6.53e-06	0.00149	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.45e-06	0.00147	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.38e-06	0.00145	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.35e-06	0.00145	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.34e-06	0.00144	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—COX2—peripheral nervous system neoplasm	6.29e-06	0.00143	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.06e-06	0.00138	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	5.86e-06	0.00133	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.86e-06	0.00133	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.84e-06	0.00133	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.7e-06	0.0013	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.64e-06	0.00128	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.63e-06	0.00128	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	5.62e-06	0.00128	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.54e-06	0.00126	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.47e-06	0.00124	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.46e-06	0.00124	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.46e-06	0.00124	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.45e-06	0.00124	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	5.41e-06	0.00123	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.39e-06	0.00123	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.12e-06	0.00117	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.03e-06	0.00115	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.01e-06	0.00114	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.85e-06	0.0011	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.81e-06	0.00109	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.79e-06	0.00109	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.77e-06	0.00109	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.67e-06	0.00106	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.65e-06	0.00106	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.63e-06	0.00105	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.45e-06	0.00101	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.4e-06	0.001	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.33e-06	0.000986	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.32e-06	0.000982	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.21e-06	0.000959	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.17e-06	0.000949	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	4.13e-06	0.000939	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.1e-06	0.000932	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.09e-06	0.00093	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	4.07e-06	0.000927	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.05e-06	0.000921	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4e-06	0.000911	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.98e-06	0.000907	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	3.91e-06	0.000889	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.9e-06	0.000888	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.79e-06	0.000862	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	3.76e-06	0.000855	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.68e-06	0.000838	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.58e-06	0.000815	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.56e-06	0.00081	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	3.55e-06	0.000808	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	3.49e-06	0.000794	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.48e-06	0.000791	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.46e-06	0.000788	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.33e-06	0.000757	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.3e-06	0.000751	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	3.28e-06	0.000746	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.06e-06	0.000696	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.03e-06	0.000689	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	3e-06	0.000683	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.99e-06	0.000681	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.97e-06	0.000676	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.89e-06	0.000658	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.86e-06	0.000651	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.84e-06	0.000646	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.83e-06	0.000645	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	2.82e-06	0.000642	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	2.68e-06	0.000609	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.66e-06	0.000606	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.63e-06	0.000599	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.63e-06	0.000598	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.6e-06	0.000592	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.56e-06	0.000582	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.55e-06	0.000581	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.53e-06	0.000577	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.49e-06	0.000566	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.47e-06	0.000562	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.46e-06	0.000559	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.44e-06	0.000555	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	2.3e-06	0.000524	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.26e-06	0.000514	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.24e-06	0.000511	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.24e-06	0.000509	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.14e-06	0.000487	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.11e-06	0.000481	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.1e-06	0.000479	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.09e-06	0.000475	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.06e-06	0.000468	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.04e-06	0.000463	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.99e-06	0.000453	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.97e-06	0.000448	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.96e-06	0.000446	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.87e-06	0.000425	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.85e-06	0.000422	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.84e-06	0.000418	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.81e-06	0.000411	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.8e-06	0.00041	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.79e-06	0.000406	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.71e-06	0.000388	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.66e-06	0.000378	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.64e-06	0.000372	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.61e-06	0.000367	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.6e-06	0.000364	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.59e-06	0.000362	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.58e-06	0.00036	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.57e-06	0.000357	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.57e-06	0.000356	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.56e-06	0.000354	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.52e-06	0.000347	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.51e-06	0.000343	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.5e-06	0.000341	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.43e-06	0.000325	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.39e-06	0.000317	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.38e-06	0.000315	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.36e-06	0.00031	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.35e-06	0.000306	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.31e-06	0.000298	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.31e-06	0.000297	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.3e-06	0.000296	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.3e-06	0.000295	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.28e-06	0.000292	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.27e-06	0.000288	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.25e-06	0.000284	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.23e-06	0.00028	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.19e-06	0.00027	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.18e-06	0.000268	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.16e-06	0.000264	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-06	0.000261	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.13e-06	0.000256	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.12e-06	0.000254	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.1e-06	0.000251	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.1e-06	0.000249	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.09e-06	0.000247	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.05e-06	0.000238	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.03e-06	0.000234	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.02e-06	0.000233	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.01e-06	0.00023	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.68e-07	0.00022	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.67e-07	0.00022	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.35e-07	0.000213	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.25e-07	0.000211	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.71e-07	0.000198	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.31e-07	0.000189	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.17e-07	0.000186	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.95e-07	0.000181	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	7.23e-07	0.000164	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.15e-07	0.000163	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.02e-07	0.00016	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.84e-07	0.000156	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	6.22e-07	0.000141	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.04e-07	0.000137	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.32e-07	9.83e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.82e-07	6.43e-05	CbGpPWpGaD
